BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30246707)

  • 41. Outcome and patterns of failure in testicular lymphoma: a multicenter Rare Cancer Network study.
    Zouhair A; Weber D; Belkacémi Y; Ketterer N; Dietrich PY; Villà S; Scandolaro L; Bieri S; Studer G; Delacretaz F; Girardet C; Mirimanoff RO; Ozsahin M;
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):652-6. PubMed ID: 11849786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium.
    Deng L; Xu-Monette ZY; Loghavi S; Manyam GC; Xia Y; Visco C; Huh J; Zhang L; Zhai Q; Wang Y; Qiu L; Dybkær K; Chiu A; Perry AM; Zhang S; Tzankov A; Rao H; Abramson J; Sohani AR; Xu M; Hsi ED; Zhu J; Ponzoni M; Wang S; Li L; Zhang M; Ferreri AJ; Parsons BM; Li Y; Piris MA; Medeiros LJ; Young KH
    Leukemia; 2016 Feb; 30(2):361-72. PubMed ID: 26308769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy.
    Touroutoglou N; Dimopoulos MA; Younes A; Hess M; Pugh W; Cox J; Cabanillas F; Sarris AH
    J Clin Oncol; 1995 Jun; 13(6):1361-7. PubMed ID: 7751880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experience.
    Zhao XY; Hong XN; Cao JN; Leaw SJ; Guo Y; Li ZT; Chang JH
    Med Oncol; 2011 Dec; 28(4):1559-64. PubMed ID: 20509008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical analyses of 24 patients with primary pulmonary NK/T-cell lymphoma].
    Qiu YJ; Zhang MZ
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):40-46. PubMed ID: 32023753
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical characterization and outcome of primary bone lymphoma: a retrospective study of 61 Chinese patients.
    Zhang X; Zhu J; Song Y; Ping L; Zheng W
    Sci Rep; 2016 Jun; 6():28834. PubMed ID: 27357354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin's Lymphoma and Role of
    Zhang Y; He D; He J; Huang W; Yang Y; Cai Z; Zhao Y
    Comput Math Methods Med; 2022; 2022():1080879. PubMed ID: 35096126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary testicular lymphoma: Clinical characteristics and oncological outcomes.
    Medina AA; Lorca Álvaro J; Carretero Del Barrio I; Laso García I; García Cosío M; Mata Alcaraz M; Hevia Palacios M; Gómez Dos Santos V; Burgos Revilla FJ
    Curr Urol; 2023 Jun; 17(2):130-134. PubMed ID: 37691992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
    El-Galaly TC; Villa D; Alzahrani M; Hansen JW; Sehn LH; Wilson D; de Nully Brown P; Loft A; Iyer V; Johnsen HE; Savage KJ; Connors JM; Hutchings M
    Am J Hematol; 2015 Nov; 90(11):1041-6. PubMed ID: 26260224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffuse large-cell lymphoma of the testis.
    Tondini C; Ferreri AJ; Siracusano L; Valagussa P; Giardini R; Rampinelli I; Bonadonna G
    J Clin Oncol; 1999 Sep; 17(9):2854-8. PubMed ID: 10561362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study.
    Yhim HY; Kang HJ; Choi YH; Kim SJ; Kim WS; Chae YS; Kim JS; Choi CW; Oh SY; Eom HS; Kim JA; Lee JH; Won JH; Shim H; Lee JJ; Sung HJ; Kim HJ; Lee DH; Suh C; Kwak JY
    BMC Cancer; 2010 Jun; 10():321. PubMed ID: 20569446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary testicular lymphoma: a single centre experience.
    Kemal Y; Teker F; Demirag G; Yucel I
    Exp Oncol; 2015 Sep; 37(3):223-6. PubMed ID: 26422109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cytarabine and hematopoietic cell transplantation for mantle cell lymphoma. Analysis of 20 patients].
    Campbell J; Hurtado S; Kutz C; Soto K; Ernst D
    Rev Med Chil; 2019; 147(1):9-17. PubMed ID: 30848759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic evaluation of the prognostic value of
    Xu P; Guo R; You J; Cheng S; Li J; Zhong H; Sun C; Xu H; Huang H; Li B; Zhao W
    Ann Hematol; 2021 Apr; 100(4):1039-1047. PubMed ID: 33634350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
    Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ
    Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of clinical characteristics and prognosis of patients with peripheral T-cell lymphoma.
    Liang X; Guo L; Hu X; Li S; Wen S
    Medicine (Baltimore); 2021 Apr; 100(13):e25194. PubMed ID: 33787601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.
    Zhu Y; Yang S; He X
    J Endocrinol Invest; 2022 Apr; 45(4):815-824. PubMed ID: 34865184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
    Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
    Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.